Back to
Dr Amy Kwon
Lecturer

Dr Amy Kwon

Medicine & Health
The Kirby Institute

BSc(Hons) (Applied Mathematics), PhD

Amy Kwon is a mathematician and a member of the modelling team led by Richard Gray in the Surveillance and Evaluation Research Program. Her research involves the development of mathematical models to understand the epidemiology of HCV and predict the impact and cost-effectiveness of interventions. She has developed and used the methodology to produce HCV estimates and assess the impact of direct-acting antiviral treatment for HCV. She is responsible for providing the key HCV estimates of prevalence and HCV-attributed disease for Australia's Annual Surveillance Report. 

Amy also works with VHEPP to assess needle and syringe distribution coverage in Australia. 

Research Interests:
HIV, HCV, HBV, AIDS, BBVs, Antiretroviral therapy, Australia, Asia, Indonesia, Mathematical modelling, Cost-effectiveness analysis, PWID, NSP, Infectious disease, Epidemiology, Public Health, Prevalence, Incidence
Phone
+61 (0)2 9385 0900
E-mail
akwon@kirby.unsw.edu.au
Location
Wallace Wurth Building, UNSW
  • Journal articles | 2023
    Cheng Q; Hoad VC; Roy Choudhury A; Seed CR; Bentley P; Shih STF; Kwon JA; Gray RT; Wiseman V, 2023, 'Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis', Vox Sanguinis, 118, pp. 471 - 479, http://dx.doi.org/10.1111/vox.13429
    Journal articles | 2023
    Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon JA; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2023, 'Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis', The Lancet Regional Health - Western Pacific, pp. 100750 - 100750, http://dx.doi.org/10.1016/j.lanwpc.2023.100750
    Journal articles | 2022
    Blach S; Terrault NA; Tacke F; Gamkrelidze I; Craxi A; Tanaka J; Waked I; Dore GJ; Abbas Z; Abdallah AR; Abdulla M; Aghemo A; Aho I; Akarca US; Alalwan AM; Alanko Blomé M; Al-Busafi SA; Aleman S; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al Serkal YM; Altraif IH; Anand AC; Anderson M; Andersson MI; Athanasakis K; Baatarkhuu O; Bakieva SR; Ben-Ari Z; Bessone F; Biondi MJ; Bizri ARN; Brandão-Mello CE; Brigida K; Brown KA; Brown, RS; Bruggmann P; Brunetto MR; Busschots D; Buti M; Butsashvili M; Cabezas J; Chae C; Chaloska Ivanova V; Chan HLY; Cheinquer H; Cheng KJ; Cheon ME; Chien CH; Chien RN; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros LE; Coco B; Contreras FA; Cornberg M; Cramp ME; Crespo J; Cui F; Cunningham CW; Dagher Abou L; Dalgard O; Dao DY; De Ledinghen V; Derbala MF; Deuba K; Dhindsa K; Djauzi S; Drazilova S; Duberg AS; Elbadri M; El-Sayed MH; Esmat G; Estes C; Ezzat S; Färkkilä MA; Ferradini L; Ferraz MLG; Ferreira PRA; Filipec Kanizaj T; Flisiak R; Frankova S; Fung J; Gamkrelidze A; Gane E; Garcia V; García-Samaniego J; Gemilyan M; Genov J; Gheorghe LS; Gholam PM; Goldis A; Gottfredsson M; Gray RT; Grebely J; Gschwantler M, 2022, 'Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study', The Lancet Gastroenterology and Hepatology, http://dx.doi.org/10.1016/S2468-1253(21)00472-6
    Journal articles | 2022
    Lim M; Devine A; Gray RT; Kwon JA; Hutchinson JL; Ong JJ, 2022, 'Lifetime cost of HIV management in Australia: an economic model', Sexual Health, 19, http://dx.doi.org/10.1071/SH21250
    Journal articles | 2021
    Kwon JA; Chambers GM; Luciani F; Zhang L; Kinathil S; Kim D; Thein HH; Botha W; Thompson S; Lloyd A; Yap L; Gray RT; Butler T, 2021, 'Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis', PLoS ONE, 16, pp. e0245896, http://dx.doi.org/10.1371/journal.pone.0245896
    Journal articles | 2021
    Kwon JA; Dore GJ; Hajarizadeh B; Alavi M; Valerio H; Grebely J; Guy R; Gray RT, 2021, 'Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications', PLoS ONE, 16, pp. e0257369, http://dx.doi.org/10.1371/journal.pone.0257369
    Journal articles | 2020
    Binka M; Janjua NZ; Grebely J; Estes C; Schanzer D; Kwon JA; Shoukry NH; Kwong JC; Razavi H; Feld JJ; Krajden M, 2020, 'Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model', JAMA Network Open, 3, pp. e204192, http://dx.doi.org/10.1001/jamanetworkopen.2020.4192
    Journal articles | 2019
    Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
    Journal articles | 2019
    Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L, 2019, 'Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016', Drug and Alcohol Dependence, 197, pp. 108 - 114, http://dx.doi.org/10.1016/j.drugalcdep.2018.11.033
    Journal articles | 2012
    Kwon J; Anderson JS; Kerr CC; Thein H; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP, 2012, 'Estimating the cost-effectiveness of needle-syringe programs in Australia.', AIDS, 26, pp. 2201 - 2210, http://dx.doi.org/10.1097/QAD.0b013e3283578b5d
    Journal articles | 2009
    Gray RT; Heymer K; Hoare A; Kwon JA; Thein H; Lote N; Siba P; Saramony S; Saphonn V; Worth H; Kaldor JM; Wilson DP, 2009, 'What impact might the economic crisis have on HIV epidemics in Southeast Asia?', Current HIV Research, 7, pp. 656 - 665, http://dx.doi.org/10.2174/157016209789973637
    Journal articles | 2009
    Kwon J; Iversen J; Maher L; Law M; Wilson D, 2009, 'The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 51, pp. 462 - 469, http://dx.doi.org/10.1097/QAI.0b013e3181a2539a
  • Preprints | 2023
    Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, , http://dx.doi.org/10.1101/2023.05.08.23289690
    Reports | 2022
    King J; McManus H; Kwon J; Gray R; McGregor S, 2022, HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2022, The Kirby Institute, UNSW Sydney, Sydney, Australia, http://dx.doi.org/10.26190/sx44-5366, https://kirby.unsw.edu.au/report/asr2022
    Reports | 2021
    Bajis S; Dore G; Alavi M; McGregor S; Kwon A; Monaghan R; Iversen J; Martinello M; Buckland G; Guy R; Kaldor J; Grebely J, 2021, Progress towards hepatitis C elimination among Aboriginal and Torres Strait Islander people in Australia: monitoring and evaluation report, The Kirby Institute, UNSW Sydney, Sydney, Australia, https://kirby.unsw.edu.au/report/progress-towards-hepatitis-c-elimination-among-aboriginal-and-torres-strait-islander-people
    Other | 2021
    Kwon J; Bretaña N; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd A; Gray R, 2021, The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19, Cold Spring Harbor Laboratory, , http://dx.doi.org/10.1101/2021.02.18.21252032
    Conference Abstracts | 2021
    Lim MHA; Devine A; Gray RT; Kwon JA; Hutchinson JL; Ong JJ, 2021, 'LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. VIII - VIII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Kwon JA; Dore G; Hajarizadeh B; Guy R; Gray RT, 2020, 'Evidence of declining HCV transmission in Australia following scale-up of direct acting antiviral therapy', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 73, pp. S606 - S606, http://dx.doi.org/10.1016/s0168-8278(20)31680-9
    Reports | 2019
    Iversen J; Heard S; Maher L; Kwon A, 2019, Needle Syringe Program National Minimum Data Collection: National Data Report 2019, https://kirby.unsw.edu.au/report/needle-syringe-program-national-minimum-data-collection-report-2019
    Reports | 2018
    Iversen J; Maher L; Heard S; Kwon A, 2018, Needle Syringe Program National Minimum Data Collection: National Data Report 2018
    Conference Posters | 2018
    Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham E; Estes C; Razavi H; Gray RT, 2018, 'Australia on track to achieve WHO elimination targets following rapid initial DAA treatment uptake', presented at International Liver Congress (European Association for the Study of the Liver (EASL 2018)), 11 April 2018 - 15 April 2018
    Conference Presentations | 2018
    Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Estes C; Homie R; Gray RT, 2018, 'Ongoing Burden of Advanced Liver Disease Complications Despite Rapid HCV Treatment Scale-Up', presented at Australasian Viral Hepatitis Conference, 13 August 2018 - 15 August 2018
    Reports | 2017
    Heard S; Iversen J; Kwon JA; Maher L, 2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2017, Australian Goverment Department of Health
    Reports | 2017
    Iversen JL; Heard S; Kwon JA; Maher L, 2017, Needle Syringe Program National Minimum Data Collection: National Data Report 2016
    Conference Presentations | 2017
    Kwon A; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Estes C; Razavi H; Gray RT, 2017, 'Australia Could Meet the WHO HCV Elimination Targets If the Current Rollout of DAA Treatment Is Continued', presented at Australasian Viral Hepatitis Conference (AVHC), 10 August 2017 - 11 August 2017
    Reports | 2011
    Wilson DP; Zhang L; Loo V; Thein HH; Gray RT; Kwon AJ, 2011, Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam, The National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney Australia
    Reports | 2010
    Wilson DP; Kwon AJ; Kerr CC; Zhang L; Hoare A, 2010, HIV in Indonesia Model, The National HIV Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, Australia
    Conference Presentations | 2009
    Kwon AJ; Iversen J; Maher L; Law MG; Wilson DP, 2009, 'The impact of NSPs on HIV and HCV transmissions in IDUs in Australia: A model-based analysis', presented at International Workshop on Modelling and Data Analysis for Infectious Disease Control, Durras, NSW, Australia, 09 March 2009 - 12 March 2009
    Conference Presentations | 2009
    Kwon AJ; Thein HH; Anderson J; Wilson DP, 2009, 'Is NSP preventing HIV and HCV epidemics among Australian IDUs?: The past and future analysis', presented at The Australasian HIV/ AIDS Conference, Brisbane, Australia, 07 September 2009 - 09 September 2009
    Reports | 2009
    Wilson D; Kwon A; Anderson J; Thein H; Law M; Maher L; Dore G; Kaldor J, 2009, Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs among injecting drug users in Australia, Publications Production Unit (Public Affairs, Parliamentary and Access Branch) Commonwealth Department of Health and Ageing, Canberra, Australia, 3123, http://www.nchecr.unsw.edu.au/nchecrweb.nsf/resources/Reports/$file/RO-2ReportLQ.pdf
    Reports | 2009
    Wilson DP; Gray R; Heymer K; Hoare A; Kwon A; Thein H; Worth H; Kaldor JM; Heymer K, 2009, Evaluation of the potential impact of the global economic crisis on HIV epidemics in Southeast Asia (prepared for AusAID), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Preprints |
    Kwon J; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT, Australia on Track to Achieve Who HCV Elimination Targets Following Rapid Initial DAA Treatment Uptake: A Modelling Study, , http://dx.doi.org/10.2139/ssrn.3213670
    Preprints |
    Lim M; Devine A; Gray RT; Kwon J; Hutchinson J; Ong J, Lifetime Cost of HIV Management in Australia: An Economic Model, , http://dx.doi.org/10.2139/ssrn.3868096
    Preprints |
    Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, , http://dx.doi.org/10.2139/ssrn.4267510